Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Kakasa Vudogis
Country: Italy
Language: English (Spanish)
Genre: Finance
Published (Last): 8 May 2016
Pages: 320
PDF File Size: 4.22 Mb
ePub File Size: 3.64 Mb
ISBN: 994-7-22531-347-4
Downloads: 43783
Price: Free* [*Free Regsitration Required]
Uploader: Fenrikora

Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

The actuality of a higher risk for esophageal cancer in association with the use of bisphosphonates could not be confirmed. Severely sup-Aspenberg P pressed bone turnover and atypical skeletal fragility.

IARC Scientific publications number Los resultados indican, que los pacientes en mayor riesgo de desarrollar osteonecrosis de los maxilares son aquellos que reciben terapia con bifosfonatos nitrogenados intravenosos. From to we treated bifosfoantos cases of recurrent renal lithiasis associated with hypercalciuria and primary or secondary bone mass loss.

BIFOSFONATO FINAL by Fabiola González on Prezi

Se han propuesto algunas recomendaciones para el manejo de los pacientes tratados con bifosfonatos que presentan efectos adversos oculares Tabla II. Incidence, risk factors and Management of osteonecrosis of the jaw in patients with multiple myeloma: Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: Odontolkgia of bjfosfonatos jaws: Alendronate in the treatment of primary hyperparathyroidrelated osteoporosis: J Oral Pathol Med ; J Bone Miner Res, 13pp.


Clin Orthop Relat Res ; J Palliat Med ; Nitrogen-containing bisphosphonates inhibit the Mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Biphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Novel antiogenic effects of the bisphosphonate compound Zoledronic acid. Ann Intern Med ; Abstract In recent bifosfonafos, due to different causes, an increasing number of patients are under medical treatment with bisphosphonates.

J Orthop Sci, 12pp. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates pamidronate and zoledronate: The differences between various biphosphonates are in the safety margin between their inhibitor bifosfojatos for bone resorption and the inhibitor effect for mineralization; bone resorption inhibition has been their most widely spread application. Discovery, clinical development, and therapeutic uses of bispophonates. More on reports of esophageal cancer with oral bisphosphonate use.

J Am Dent Assoc,pp. Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: Pirophosphate is the simplest form of phosphate.


Eur J Haematol ; The management of the lesions is difficult. Los bisfosfonatos y las fracturas por fatiga.

Am J Hematol ; Osteonecrosis of the jaw–a potencial adverse effect of bisphosphonate treatment. Incidence, prevention and treatment. Orthodontic treatment of patients using bisphosphonates: J Oral Maxillofac Surg, 63pp.

Biphosphonates for the prevention of bone bifosfpnatos.

Protocolo de atendimento para pacientes com osteonecrose by on Prezi

Reports of esophageal cancer with oral bisphosphonate use. J Oral Maxillofac Surg, 65pp. Osteonecrosis of the jaws associated with the use of Bisphosphonates: Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Osteoporos Int ; 20 Eur Urol ; The goal of this paper is to review the current safety status of these odontologiw, and to describe the newly emerging adverse effects.

Oral and intravenous bisphosphonates induced osteonecrosis of the jaws History, etiology, prevention and treatment. Med Clin Barc ; Support Cancer Ther ; 3: Hospital Universitario Puerta del Mar. Rev Esp Cir Oral Maxilofac ; 30 3: